Testing a Web-based Intervention for Radioactive Iodine Symptom Management (RAI Support) to Improve Health-related Quality of Life Among Differentiated Thyroid Cancer Patients
Launched by GEORGETOWN UNIVERSITY · Feb 25, 2025
Trial Information
Current as of July 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking into a new online tool called RAI Support, designed to help adults diagnosed with differentiated thyroid cancer manage symptoms and improve their quality of life after receiving radioactive iodine (RAI) treatment. The researchers want to find out if patients can easily use this tool and if it helps them feel better overall compared to the usual care provided, which is an informational website about thyroid cancer.
To participate in the trial, you need to be at least 18 years old, have been diagnosed with differentiated thyroid cancer, and have received RAI treatment within the last three years. Participants will be randomly assigned to either use the RAI Support tool or the usual informational website for four weeks and will share their experiences by completing two online questionnaires about their symptoms and well-being. There's also an option for a virtual interview to discuss how the website worked for them. This study aims to improve support for thyroid cancer survivors, making it easier for them to manage their health after treatment.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18 or older (papillary or follicular carcinoma)
- • Diagnosed with differentiated thyroid cancer
- • Received radioactive iodine (RAI) treatment less than or equal to three years ago.
- • Mild to moderate symptoms of RAI
- • Able to provide informed consent in English
- • Access to a computer, tablet, or smartphone with internet connectivity
- Exclusion Criteria:
- • A condition that precludes providing informed consent or completing study procedures (cognitive or psychiatric condition, hearing problems) as identified by the patient's physician or as assessed by a trained study team member.
About Georgetown University
Georgetown University is a prestigious academic institution renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, Georgetown University leverages its extensive resources and expertise to conduct innovative research that addresses critical health challenges. The university fosters collaboration among multidisciplinary teams, emphasizing ethical practices and adherence to regulatory standards. With a focus on translating scientific discoveries into clinical applications, Georgetown University plays a vital role in enhancing patient care and contributing to the broader medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported